-
EP2188255
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2188255
| EP2188255 - HETEROCYCLIC AMIDES USEFUL FOR THE TREATMENT OF CANCER AND PSORIASIS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 02.09.2011 Database last updated on 08.06.2024 | Most recent event Tooltip | 02.09.2011 | Application deemed to be withdrawn | published on 05.10.2011 [2011/40] | Applicant(s) | For all designated states AstraZeneca AB 151 85 Södertälje / SE | [2010/21] | Inventor(s) | 01 /
DAKIN, Leslie AstraZeneca R&D Boston 35 Gatehouse Drive Waltham, Massachusetts 02451 / US | 02 /
FAUBER, Benjamin AstraZeneca R&D Boston 35 Gatehouse Drive Waltham, Massachusetts 02451 / US | 03 /
HIRD, Alexander AstraZeneca R&D Boston 35 Gatehouse Drive Waltham, Massachusetts 02451 / US | 04 /
JANETKA, James AstraZeneca R&D Boston 35 Gatehouse Drive Waltham, Massachusetts 02451 / US | 05 /
RUSSELL, Daniel, John AstraZeneca R&D Boston 35 Gatehouse Drive Waltham, Massachusetts 02451 / US | 06 /
SU, Qibin AstraZeneca R&D Boston 35 Gatehouse Drive Waltham, Massachusetts 02451 / US | 07 /
YANG, Bin AstraZeneca R&D Boston 35 Gatehouse Drive Waltham, Massachusetts 02451 / US | 08 /
ZHENG, XiaoLan AstraZeneca R&D Boston 35 Gatehouse Drive Waltham, Massachusetts 02451 / US | [2010/21] | Application number, filing date | 08788726.1 | 29.08.2008 | [2010/21] | WO2008GB50756 | Priority number, date | US20070969364P | 31.08.2007 Original published format: US 969364 P | US20080036658 | 14.03.2008 Original published format: US 36658 | [2010/21] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2009027746 | Date: | 05.03.2009 | Language: | EN | [2009/10] | Type: | A1 Application with search report | No.: | EP2188255 | Date: | 26.05.2010 | Language: | EN | The application published by WIPO in one of the EPO official languages on 05.03.2009 takes the place of the publication of the European patent application. | [2010/21] | Search report(s) | International search report - published on: | EP | 05.03.2009 | Classification | IPC: | C07D213/30, C07D213/40, C07D213/73, C07D233/61, C07D401/12, C07D413/12, C07D417/12, C07D417/14, C07D473/00, C07D513/04, A61K31/40, A61K31/41, A61K31/435, A61K31/4427, A61P35/00 | [2010/21] | CPC: |
C07D401/12 (EP,US);
A61P17/06 (EP);
A61P35/00 (EP);
A61P37/00 (EP);
C07D213/30 (EP,US);
C07D213/40 (EP,US);
C07D213/73 (EP,US);
C07D233/61 (EP,US);
C07D413/12 (EP,US);
C07D417/12 (EP,US);
C07D417/14 (EP,US);
C07D473/00 (EP,US);
C07D513/04 (EP,US)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2010/21] | Extension states | AL | 31.03.2010 | BA | 31.03.2010 | MK | 31.03.2010 | RS | 31.03.2010 | Title | German: | ZUR BEHANDLUNG VON KREBS UND PSORIASIS GEEIGNETE HETEROCYCLISCHE AMIDE | [2010/21] | English: | HETEROCYCLIC AMIDES USEFUL FOR THE TREATMENT OF CANCER AND PSORIASIS | [2010/21] | French: | AMIDES HÉTÉROCYCLIQUES UTILES DANS LE TRAITEMENT DU CANCER ET DU PSORIASIS | [2010/21] | Entry into regional phase | 31.03.2010 | National basic fee paid | 31.03.2010 | Designation fee(s) paid | 31.03.2010 | Examination fee paid | Examination procedure | 31.03.2010 | Examination requested [2010/21] | 21.05.2010 | Amendment by applicant (claims and/or description) | 20.09.2010 | Despatch of a communication from the examining division (Time limit: M06) | 31.03.2011 | Application deemed to be withdrawn, date of legal effect [2011/40] | 09.05.2011 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2011/40] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 20.09.2010 | Fees paid | Renewal fee | 31.08.2010 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO2004073634 (ENCYSIVE PHARMACEUTICALS INC [US], et al) [X] 1-9 * page 45; compound 112 *; | [X]WO2004072025 (AVENTIS PHARMA GMBH [DE]) [X] 1-9 * compounds 679, 947, 1100 *; | [X]WO2007049532 (SHIONOGI & CO [JP], et al) [X] 1-9 * page 128; compound 313 * * page 140; compound 426 * * page 145; compound 477 *; | [A]WO2006028958 (GENENTECH INC [US], et al) [A] 1-15 * the whole document * |